Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Jun 15;13(12):2897-903.
doi: 10.1002/j.1460-2075.1994.tb06584.x.

Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein

Affiliations

Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein

C Hagemeier et al. EMBO J. .

Abstract

The 86 kDa immediate early IE2 protein of human cytomegalovirus (HCMV) can activate transcription of both viral and cellular genes and can repress transcription from its own promoter. Using two in vivo assays, we provide evidence of a functional interaction between IE2 and the retinoblastoma (RB) protein: IE2 alleviates RB-induced repression of a promoter bearing E2F binding sites and RB alleviates IE2-mediated repression of its own promoter. These functional effects are likely to be a result of a direct contact between IE2 and RB, which we can demonstrate both in vitro and in HCMV-infected cells. The interaction between IE2 and RB shows similar characteristics to the interaction between RB and E1A. First, binding to IE2 requires an intact RB pocket domain. Secondly, the binding is sensitive to the phosphorylation state of RB, because cyclin A-CDK-induced phosphorylation of RB diminishes IE2 binding. Thirdly, the IE2 domain required for RB binding is separate to the domains necessary for TBP and TFIIB binding. Our results demonstrate that large and small DNA viruses have a common interface with the host cell, namely the association with the RB tumour suppressor protein.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Gen Virol. 1977 Oct;37(1):65-73 - PubMed
    1. Nature. 1991 Aug 8;352(6335):541-4 - PubMed
    1. J Virol. 1990 Apr;64(4):1498-506 - PubMed
    1. J Gen Virol. 1993 Dec;74 ( Pt 12):2691-8 - PubMed
    1. Cell. 1992 Jul 24;70(2):337-50 - PubMed

Publication types